Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019



Shelagh  McKinlay

Shelagh McKinlay

Head of Patient Advocacy, Myeloma UK

As Head of Patient Advocacy at Myeloma UK, Shelagh is responsible for making sure the patient voice is heard and acted on by decision makers. She leads the patient advocacy team in helping to deliver access to the best new myeloma treatments, influencing cancer strategies and developing new ways of working with patients and their families. Shelagh has 25 years’ experience in high profile policy and public affairs roles, including Head of Corporate Affairs at one of Scotland’s largest primary care NHS Trusts and 10 years leading a committee clerking team at the Scottish Parliament. Shelagh has also worked as a writer, a policy consultant and as a campaigner in democratic engagement. She is an advisor to the Board of the Scottish Youth Parliament.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd